WJCD  Vol.4 No.5 , May 2014
Microalbuminuria in White and Black Hypertensive Nondiabetic Brazilian Patients
ABSTRACT
Microalbuminuria (MAU) is a predictor of cardiovascular mortality in patients with diabetes mellitus (DM) and hypertension (HTN) and also in an unselected population. The American Diabetes Association (ADA) and the National Kidney Foundation (NKF) define MAU as an albumin/creatinine ratio (ACR) between 30 and 300 μg/mg in both men and women. Aim: To evaluate the possible relationship among MAU, HTN and gender and ethnicity in Brazilian nondiabetic primary hypertensive patients. Design: Population-based study. Participants: Ninety-eight men and women, seventy-two black and twenty-six white nondiabetic primary hypertensive patients aged 20 years or older were selected. Forty healthy individuals, paired according to age, gender, and ethnics were used as controls. Methods: Early-morning midstream urine was used. Urinary albumin was spectrophotometrically measured with Coomassie Brillant Blue G-250. Creatinine was determined by a method based on Jaffe’s reaction. ACR (μg albumin/mg creatinine) was calculated. Data are expressed as medians. Results: ACR level was significantly higher in 98 hypertensive patients (38.00) than in 40 control individuals (23.00) (P < 0.001). ACR level was significantly higher in 48 hypertensive male (46.00) than in 50 hypertensive female (34.00) (P = 0.008). No significant effect of ethnicity on ACR levels between 26 hypertensive Whites (35.50) and 72 hypertensive Blacks (38.00) was observed (P = 0.978). Conclusions: The ACR level, significantly higher in hypertensive patients than in control individuals, supports data from the literature. To our knowledge, this is the first study demonstrating that the ACR level is significantly higher in men than in women. The lack of an ethnicity effect supports what was already asserted, namely, that in Brazil, at an individual level, color, as determined by physical evaluation, is a poor predictor of genomic African ancestry, as estimated by molecular markers.

Cite this paper
Belo, A. , Machado, E. , de Souza Figueiredo, A. and Figueiredo, E. (2014) Microalbuminuria in White and Black Hypertensive Nondiabetic Brazilian Patients. World Journal of Cardiovascular Diseases, 4, 236-243. doi: 10.4236/wjcd.2014.45031.
References
[1]   Song, C.K., Martinez, J.A., Kailasam, M.T., Dao, T.T., Wong, C.M., Parmer, R.J. and O’Connor, D.T. (2000) Renalkallikrein Excretion: Role of Ethnicity, Gender, Environment, and Genetic Risk of Hypertension. Journal of Human Hypertension, 14, 461-468.
http://dx.doi.org/10.1038/sj.jhh.1001047

[2]   Krieger, J.E. and Dzau, V. (1991) Molecularbiology of Hypertension. Hypertension, 18, I3-17.
http://dx.doi.org/10.1161/01.HYP.18.3_Suppl.I3

[3]   Sun, Z. and Zhang, Z. (2005) Historic Perspectives and Recent Advances in Major Animal Models of Hypertension. Acta Pharmacologica Sinica, 26, 295-301.
http://dx.doi.org/10.1111/j.1745-7254.2005.00054.x

[4]   van de Wal, R.M.A., Asselbergs, F.W., Plokker, H.W.T., Smilde, T.D., van Veldhuilduisen, D.J., et al. (2005) High Prevalence of Microalbuminuria in Chronic Heart Failure Patients. Journal of Cardiac Failure, 11, 602-606.
http://dx.doi.org/10.1016/j.cardfail.2005.05.007

[5]   Mattix, H.J., Hsu, C., Shaykevich, S. and Curhan, G. (2002) Use of the Albumin/Creatinine Ratio to Detect Microalbuminuria: Implications of Sex and Race. Journal of the American Society of Nephrology, 13, 1034-1039.

[6]   American Diabetes Association (2001) Clinical Practice Recommendations 2001: Diabetic Nephropathy. Diabetes Care, 24, S69-S72.

[7]   Keane, W.F. and Eknoyan, G. (1999) Proteinuria, Albuminuria, Risk, Assessment, Detection, Elimination [PARADE]: A Position Paper of the National Kidney Foundation. American Journal of Kidney Diseases, 33, 1004-1010.
http://dx.doi.org/10.1016/S0272-6386(99)70442-7

[8]   Böhm, M., Thoenes, M., Danchin, N., Bram-lage, P., La Puerta, P. and Volpe, M. (2007) Association of Cardiovascular Risk Factors with Microalbuminuria in Hypertensive Individuals: The i-SEARCH Global Study. Journal of Hypertension, 25, 2317-2324.
http://dx.doi.org/10.1097/HJH.0b013e3282ef1c5f

[9]   Haller, H., Menne, J. and Mancia, G. (2010) Awareness and Behaviour of European Physicians in Relation to Microalbuminuria and Organ Damage: An ESH-Endorsed Survey. Journal of Hypertension, 28, 2204-2209.
http://dx.doi.org/10.1097/HJH.0b013e32833cfd40

[10]   Johnson, A.M. (2006) Amino-Acids, Peptides and Proteins. In: Burtis, C.A., Ashwood, E.R. and Bruns, D.E., Eds., Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 4th Edition, Elsevier Sounders, Philadelphia, 533-595.

[11]   Giusti, E.P., Sampaio, C.A.M., Michelacci, Y.M., Stella, R.C., Oliveira, L. and Prado, E.S. (1988) Horse Urinary Kallikrein, I. Complete Purification and Characterization. Biological Chemistry Hoppe-Seyler, 369, 387-396.
http://dx.doi.org/10.1515/bchm3.1988.369.1.387

[12]   Bradford, M.M. (1976) A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Analytical Biochemistry, 72, 248-254.
http://dx.doi.org/10.1016/0003-2697(76)90527-3

[13]   Peterson, G.L. (1983) Determination of Total Protein. Methods in Enzymology, 91, 95-119.
http://dx.doi.org/10.1016/S0076-6879(83)91014-5

[14]   Parving, H.H., Mogensen, C.E., Jensen, H.A.E. and Evrin, P.E. (1974) Increased Urinary Albumin Excretion Rate in Benign Essential Hypertension. The Lancet, 1, 1190-1192.
http://dx.doi.org/10.1016/S0140-6736(74)91002-2

[15]   Olinic, N., Vida-Simiti, L., Cristea, A. and Muresan, A. (1994) Microalbuminuria in Hypertensive Patients. Romanian Journal of Internal Medicine, 32, 17-21.

[16]   Pontremoli, R., Sofia, A., Ravera, M., Nicolella, C., Viazzi, F., Tirotta, A., et al. (1997) Prevalence and Clinical Correlates of Microalbuminuria in Essential Hypertension: The MAGIC Study. Hypertension, 30, 1135-1143.
http://dx.doi.org/10.1161/01.HYP.30.5.1135

[17]   de la Sierra, A., Bragulat, E., Sierra, C., Gomez-Angelats, E., Antonio, M.T., et al. (2000) Microalbuminuria in Essential Hypertension: Clinical and Biochemical Profile. British Journal of Biomedical Science, 57, 287-291.

[18]   Jensen, J.S., Feldt-Rasmussen, B., Strandgaard, S., Schroll, M. and Borch-Johnsen, K. (2000) Arterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart Disease. Hypertension, 35, 898-903.
http://dx.doi.org/10.1161/01.HYP.35.4.898

[19]   Reboldi, G., Gentile, G., Angeli, F. and Verdecchia, P. (2005) Microalbuminuria and Hypertension. Minerva Medica, 96, 261-275.

[20]   Summerson, J.H., Bell, R.A. and Konen, J.C. (1995) Racial Differences in the Prevalence of Microalbuminuria in Hypertension. American Journal of Kidney Diseases, 26, 577-579.
http://dx.doi.org/10.1016/0272-6386(95)90591-X

[21]   Arar, N., Nath, S., Thameen, F., Bauer, R., Voruganti, S., et al. (2007) Genome-Wide Scans for Microalbuminuria in Mexican Americans: The San Antonio Family Heart Study. Genetic Medicine, 9, 80-87.
http://dx.doi.org/10.1097/GIM.0b013e31803068ec

[22]   Parra, F.C., Amado, R.C., Lambertucci, J.R., Rocha, J., Antunes, C.M. and Pena, S.D.J. (2003) Color and Genomic Ancestry in Brazilians. Proceedings of the National Academy of Sciences of the United States of America, 100, 177-182.
http://dx.doi.org/10.1073/pnas.0126614100

 
 
Top